Satellos Bioscience Inc., a clinical-stage company focused on treatments for degenerative muscle diseases, announced its management will participate in two investor conferences in November: the Guggenheim Healthcare Innovation Conference on Nov 9 in Boston and the Jefferies Global Healthcare Conference on Nov 18-19 in London. The company is developing forazapadin, a drug in Phase 2 trials targeting Duchenne muscular dystrophy and other muscle diseases, with plans to start a new trial for facioscapulohumeral muscular dystrophy in late 2026. Satellos aims to expand its clinical development into additional muscle conditions. Replays of the events will be available on the company website.
Satellos Bioscience's upcoming investor conference participation is noted alongside Pluang's snapshot of the Health sector. As of Oct 21, 2026 18:11 WIB, out of 150 priced Health-sector US stocks tradable on Pluang, 71 rose and 67 fell. Notable movers include NUVB at USD 4.91 with a 1-day change of +2.94% and a typical hold time of 12 days, BNGO at USD 1.21 down 2.81% with a 51-day hold time and 100% sell order activity, and ZBH at USD 93.60 down 2.50% with an 89-day hold time and 100% sell order activity.
YYForce Inc. has purchased 20 wearable data collection systems to gather real task data from hotel room service at Novotel Singapore. This project aims to record and analyze experienced staff performing tasks like bed-making, towel folding, and clean...
The global digital health and remote patient monitoring market is projected to grow from $26.8 billion in 2025 to $80.8 billion by 2031, at a compound annual growth rate of 20.2%. This growth is driven by increasing demand for chronic disease managem...
The global private credit and alternative lending market, valued at $2.31 trillion in 2026, is expected to grow at a 7.8% CAGR to reach $3.36 trillion by 2031. Recent liquidity pressures in 2025, triggered by bankruptcies and AI sector concerns, caus...
The global data center wire and cable market is projected to grow from USD 18.17 billion in 2025 to approximately USD 27.42 billion by 2031, at a CAGR of 7.1%. This growth is fueled by the rapid expansion of AI data centers, which increases demand fo...
China's non-resilient floor covering market, valued at $42.85 billion in 2025, is projected to grow at a 4% CAGR to $58.52 billion by 2035. Growth is fueled by ongoing residential construction, property renovations, and commercial real estate develop...
